Tell a friend

Donate

Email sign-up

defending the First Amendment against the Christian right ...

Jews On First!

... because if Jews don't speak out, they'll think we don't mind

Concerned Women for America Leader Lauds FDA's Handling of Plan B Drug Review Process

By Mary Rettig, Agape Press, November 22, 2005

(AgapePress) - The results of an investigation by the Government Accountability Office (GAO) into how the Food and Drug Administration has dealt with the so-called "emergency" contraceptive drug known as Plan B has caused liberal U.S. senators some concern. However, a spokesperson for Concerned Women for America (CWA) says her group is pleased with the FDA's handling of the drug sometimes referred to as the "morning-after pill."

CWA executive vice president Wendy Wright says the GAO recently released a report after Senators Hillary Clinton (D-NY) and Patty Murray (D-WA) demanded an investigation into why the FDA had not approved Plan B for over-the-counter sales. Wright says the report found that leadership within the federal agency intervened in the decision and stopped the drug from being approved for non-prescription use.

"We say that was rightfully so," the CWA spokeswoman asserts, "because there has been a problem within the FDA of it approving controversial drugs such as RU-486. There are too many people within the FDA who have the mindset that death is preferable to pregnancy."

Emergency contraceptive drugs such as Plan B contain high doses of hormones that can prevent pregnancy from occurring after unprotected sex, often by inhibiting ovulation or fertilization or possibly, in some cases, by preventing implantation of an embryo after fertilization has occurred. While the use of Plan B itself may not carry grave health risks, Wright believes easy accessibility of the drug without a prescription could encourage a false sense of security that could prove dangerous, if not lethal.

With the morning-after pill, the pro-family leader notes, "There doesn't seem to be risk of it causing death; however, making it easily available can lead to life-threatening complications, such as by encouraging risky sexual behavior. There'll be an increase in sexually transmitted diseases -- and STDs can lead to serious health problems, including death."

It is appropriate for the FDA leadership to intervene in the review process for a drug like Plan B, Wright contends, especially when the lower levels of employees were not taking the possible public health risks of approval seriously.




Fair Use Statement: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.